Centro de investigação Champalimaud

Não é todos os dias que se lê isto na prestigiada imprensa internacional: Thanks to €500 million inherited from its richest man, Portugal will unveil a medical research center next month that could put it at the forefront of advances against cancer.

Tudo isto graças a um doador privado: While American research has long benefited from such private donations, most of the financing in Europe has come from governments or pharmaceutical companies. In Germany, for instance, the Max Planck Society relies exclusively on public financing, while the country’s other leading research institute, the Fraunhofer Society, gets its money evenly split from the public and business.

E ficará isto em Portugal: The center will be inaugurated on Oct. 5 but will start operating only next year, gradually filling to a capacity of 500 researchers working alongside 100 physicians handling about 300 patients daily. That level of interaction is what the center’s backers claim will be unique, an approach also welcomed by other independent researchers.

Fundação Champalimaud: Centro de Investigação

Fonte: aqui.

The Champalimaud Research Centre will be a multidisciplinary centre for translational research of excellence, with the best possible conditions to attract and retain the best researchers, academics and medical doctors from Portugal and abroad in the fields of neurosciences and oncology. The Champalimaud Research Centre will include laboratories for basic and clinical research, an ambulatory care centre, a vivarium, an auditorium, conference rooms and other teaching facilities and also an exhibition area.

O Centro de Investigação Champalimaud, materializa o objectivo da Fundação Champalimaud de construir um centro de investigação científica multidisciplinar translacional de referência no campo da biomedicina, que garanta as condições ideais para que investigadores e académicos nacionais e estrangeiros desenvolvam projectos de excelência com aplicação clínica (prevenção, diagnóstico e tratamento), nas áreas das neurociências e da oncologia. O Centro disporá das melhores condições e das mais modernas tecnologias para investigação biomédica, bem como das infra-estruturas necessárias ao ensino pós-graduado e a programas de mestrado e de doutoramento no campo da biomedicina.